{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-2872"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-2872","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"Exploring the Molecular Pathways of Cell Death Induced by PDE3 Modulators","abstract":"Metabolic dysregulation, a critical hallmark of cancer, predisposes potential vulnerabilities for the development of targeted therapy. LKB1, a pivotal metabolic regulator and tumor suppressor, is often lost in many cancers. Our laboratory has unveiled that LKB1 suppresses phosphodiesterases (PDEs), and PDE3 modulators can selectively eradicate LKB1-deficient tumor cells. Through metabolic gene sgRNA library screening, Sarcolipin, an inhibitor of Sarcoendoplasmic Reticulum Calcium ATPase (SERCA), emerged as essential for cell death in this context. However, the precise molecular mechanisms by which PDE3 modulators exert their effects remain elusive. This study aims to uncover these mechanisms via RNA-Seq profiling and differential gene analysis, revealing that PDE3 modulators trigger significant ER stress and ribotoxic stress responses. Further exploration of various pathways through inhibitors and activators demonstrated that activation of SERCA mitigates stress responses and counteracts the cell death triggered by PDE3 modulators. Our findings help define a targeted therapy for cancers harboring LKB1 mutations.","abstract_html":"Metabolic dysregulation, a critical hallmark of cancer, predisposes potential vulnerabilities for the development of targeted therapy. LKB1, a pivotal metabolic regulator and tumor suppressor, is often lost in many cancers. Our laboratory has unveiled that LKB1 suppresses phosphodiesterases (PDEs), and PDE3 modulators can selectively eradicate LKB1-deficient tumor cells. Through metabolic gene sgRNA library screening, Sarcolipin, an inhibitor of Sarcoendoplasmic Reticulum Calcium ATPase (SERCA), emerged as essential for cell death in this context. However, the precise molecular mechanisms by which PDE3 modulators exert their effects remain elusive. This study aims to uncover these mechanisms via RNA-Seq profiling and differential gene analysis, revealing that PDE3 modulators trigger significant ER stress and ribotoxic stress responses. Further exploration of various pathways through inhibitors and activators demonstrated that activation of SERCA mitigates stress responses and counteracts the cell death triggered by PDE3 modulators. Our findings help define a targeted therapy for cancers harboring LKB1 mutations.","abstract_has_math":false,"creators":["Ahsan, Aqsa"],"institution":null,"degree_name":"Master of Science in Biological Sciences (MS)","degree_level":"Open Access Master's Thesis","degree_discipline":"Department of Biological Sciences","degree_department":null,"school":null,"contributors":["Xiaohu Tang"],"advisors":[],"committee_chairs":[],"committee_members":["Zhiying Shan","Marina Tanasova"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:19:03Z","subjects":["LKB1","PDE3","Metabolic Reprogramming","Targeted Therapy","Cancer Biology","Molecular Biology"],"languages":[],"rights":[],"rights_urls":["http://creativecommons.org/licenses/by-nc-sa/4.0/"],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/1728"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/1728","href":"https://digitalcommons.mtu.edu/etdr/1728","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/1728","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/1728","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-2872","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Xiaohu Tang"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Zhiying Shan","Marina Tanasova"]},{"key":"dc:creator","label":"Author","values":["Ahsan, Aqsa"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-04-15T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Master's Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Biological Sciences (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["LKB1","PDE3","Metabolic Reprogramming","Targeted Therapy","Cancer Biology","Molecular Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.license","label":"Dc Rights License","values":["http://creativecommons.org/licenses/by-nc-sa/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/1728","https://digitalcommons.mtu.edu/etdr/1728"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Metabolic dysregulation, a critical hallmark of cancer, predisposes potential vulnerabilities for the development of targeted therapy. LKB1, a pivotal metabolic regulator and tumor suppressor, is often lost in many cancers. Our laboratory has unveiled that LKB1 suppresses phosphodiesterases (PDEs), and PDE3 modulators can selectively eradicate LKB1-deficient tumor cells. Through metabolic gene sgRNA library screening, Sarcolipin, an inhibitor of Sarcoendoplasmic Reticulum Calcium ATPase (SERCA), emerged as essential for cell death in this context. However, the precise molecular mechanisms by which PDE3 modulators exert their effects remain elusive. This study aims to uncover these mechanisms via RNA-Seq profiling and differential gene analysis, revealing that PDE3 modulators trigger significant ER stress and ribotoxic stress responses. Further exploration of various pathways through inhibitors and activators demonstrated that activation of SERCA mitigates stress responses and counteracts the cell death triggered by PDE3 modulators. Our findings help define a targeted therapy for cancers harboring LKB1 mutations."]},{"key":"dc:title","label":"Title","values":["Exploring the Molecular Pathways of Cell Death Induced by PDE3 Modulators"]}]}],"canonical_facts":{"dc:contributor":["Xiaohu Tang"],"dc:contributor.committeemember":["Zhiying Shan","Marina Tanasova"],"dc:creator":["Ahsan, Aqsa"],"dc:date.available":["2025-04-15T07:00:00Z"],"dc:date.created":["2024-01-01T08:00:00Z"],"dc:description.abstract":["Metabolic dysregulation, a critical hallmark of cancer, predisposes potential vulnerabilities for the development of targeted therapy. LKB1, a pivotal metabolic regulator and tumor suppressor, is often lost in many cancers. Our laboratory has unveiled that LKB1 suppresses phosphodiesterases (PDEs), and PDE3 modulators can selectively eradicate LKB1-deficient tumor cells. Through metabolic gene sgRNA library screening, Sarcolipin, an inhibitor of Sarcoendoplasmic Reticulum Calcium ATPase (SERCA), emerged as essential for cell death in this context. However, the precise molecular mechanisms by which PDE3 modulators exert their effects remain elusive. This study aims to uncover these mechanisms via RNA-Seq profiling and differential gene analysis, revealing that PDE3 modulators trigger significant ER stress and ribotoxic stress responses. Further exploration of various pathways through inhibitors and activators demonstrated that activation of SERCA mitigates stress responses and counteracts the cell death triggered by PDE3 modulators. Our findings help define a targeted therapy for cancers harboring LKB1 mutations."],"dc:identifier":["10.37099/mtu.dc.etdr/1728","https://digitalcommons.mtu.edu/etdr/1728"],"dc:rights.license":["http://creativecommons.org/licenses/by-nc-sa/4.0/"],"dc:subject":["LKB1","PDE3","Metabolic Reprogramming","Targeted Therapy","Cancer Biology","Molecular Biology"],"dc:title":["Exploring the Molecular Pathways of Cell Death Induced by PDE3 Modulators"],"thesis:degree_discipline":["Department of Biological Sciences"],"thesis:degree_level":["Open Access Master's Thesis"],"thesis:degree_name":["Master of Science in Biological Sciences (MS)"]},"updated_at":"2026-11-19T08:19:03Z"}